BRAF Targets in Melanoma: Biological Mechanisms, Resistance, and Drug Discovery

Author:   Ryan J. Sullivan
Publisher:   Humana Press Inc.
Edition:   2015 ed.
Volume:   82
ISBN:  

9781493921423


Pages:   204
Publication Date:   25 November 2014
Format:   Hardback
Availability:   Manufactured on demand   Availability explained
We will order this item for you from a manufactured on demand supplier.

Our Price $290.37 Quantity:  
Add to Cart

Share |

BRAF Targets in Melanoma: Biological Mechanisms, Resistance, and Drug Discovery


Add your own review!

Overview

​This volume contains a collection of writings from the leaders in the fields of Molecular Biology and Melanoma Research which will begin to tell the ever-expanding story of the most recent findings, discoveries, and potential of BRAF-directed targets in melanoma. Recent research has shown that BRAF inhibitors are effective for a short period of time, but there is little hope that this drugs as single agents will lead to durable benefit in a majority of patients. Among scientists and researchers who work in drug discovery, there is a lot of interest in the development of molecularly targeted cancer agents. Namely, the identification of a molecular target, the selection of molecules which effectively inhibit this target. What is starkly different about the development of this class of compounds, however, is that the mechanism of action of these agents are not as straightforward as was once previously assumed and the mechanisms of resistance that tumor cells employ to evade complete destruction are unlike any that have been described before. These discoveries in addition to utilization of modern molecular biology techniques have led to a series of hypotheses regarding which other types of molecules could be used in combination with BRAF-inhibitors in hopes of revolutionizing the potential of therapeutics in melanoma.

Full Product Details

Author:   Ryan J. Sullivan
Publisher:   Humana Press Inc.
Imprint:   Humana Press Inc.
Edition:   2015 ed.
Volume:   82
Dimensions:   Width: 15.50cm , Height: 1.30cm , Length: 23.50cm
Weight:   4.439kg
ISBN:  

9781493921423


ISBN 10:   1493921428
Pages:   204
Publication Date:   25 November 2014
Audience:   Professional and scholarly ,  Professional & Vocational
Format:   Hardback
Publisher's Status:   Active
Availability:   Manufactured on demand   Availability explained
We will order this item for you from a manufactured on demand supplier.

Table of Contents

Melanoma: Historical Context.- Melanoma Pathogenesis.- Molecular Diagnostics and Tumor Mutational Analysis.- Clinical Utility of BRAF-targeted therapy in Melanoma.- The Ethics of Randomized Trials in Oncology.- Parallel and Serial Blockade Strategies in BRAF-Mutant Melanoma.- Targeting the cell cycle and p53 in combination with BRAF-directed therapy.- Combination BRAF-directed therapy and immunotherapy.- Moving Forward: Making BRAF-Targeted Therapy Better.

Reviews

Author Information

Dr. Ryan J. Sullivan is affiliated with Massachusetts General Hospital and Dana Farber. His research interests are in the development of novel molecular therapeutic agents for Kaposi sarcoma (KS) and malignant melanoma and the translation of promising preclinical findings into early stage clinical trials. He serves as the co-director of the Eugene Michael Egan Melanoma Translational Research Laboratory at Beth Israel Deaconess Medical Center (BIDMC) and is actively investigating promising biomarkers of response and benefit to immunotherapy and molecular targeted therapy for patients with melanoma.

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions
Latest Reading Guide

MRG2025CC

 

Shopping Cart
Your cart is empty
Shopping cart
Mailing List